Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Siegfried Holding AG ( (CH:SFZN) ) has issued an update.
Siegfried has agreed to acquire the drug substance business of the Noramco Group and Extractas Bioscience from an affiliate of SK Capital Partners, adding three small-molecule manufacturing sites: Noramco in Wilmington, Delaware, Purisys in Athens, Georgia, and Extractas Bioscience in Westbury, Tasmania, together employing around 400 staff. The deal significantly expands Siegfried’s US-based capacity in small-molecule drug substances and controlled substances, complements its existing Pennsville site and early-phase development capabilities, and enhances its extraction expertise, thereby strengthening its integrated CDMO offering and positioning in key growth segments; valued at under 10 times EV/EBITDA and financed with existing and new debt, the transaction is designed to be value accretive and to support the company’s EVOLVE+ strategy of accelerating long-term profitable growth in the world’s largest pharmaceutical market.
The most recent analyst rating on (CH:SFZN) stock is a Hold with a CHF93.00 price target. To see the full list of analyst forecasts on Siegfried Holding AG stock, see the CH:SFZN Stock Forecast page.
More about Siegfried Holding AG
Siegfried Holding AG is a global life sciences company and leading contract development and manufacturing organization (CDMO) for the pharmaceutical industry, specializing in the production of active pharmaceutical ingredients (APIs), intermediates and finished dosage forms such as tablets, capsules and sterile injectables. Headquartered in Zofingen, Switzerland, the group operates 13 sites across Europe, the US and China, generated CHF 1.295 billion in sales in 2024 and employs more than 3,800 people, serving pharma customers worldwide with integrated development and manufacturing services.
Average Trading Volume: 107,498
Technical Sentiment Signal: Buy
Current Market Cap: CHF3.92B
For detailed information about SFZN stock, go to TipRanks’ Stock Analysis page.